SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is generating significant buzz as traders highlight its recent momentum and speculative potential, with the community actively debating whether it can sustain a parabolic run or if liquidity is shifting toward newer meme projects. Enthusiasts are fixated on 'zero-dropping' price action and aggressive buying catalysts, while some skeptical voices warn of the volatility typical of low-cap crypto assets.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community maintains a patient, long-term outlook, frequently discussing the project's potential for future growth despite recent price consolidation. Supporters are actively engaging with the ecosystem's utility, including staking options and the health-focused rewards model, while some users look forward to a potential long-term turnaround for the token.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as community members rally behind the belief that increasing on-chain burns and potential regulatory developments could trigger a major recovery. Discussion is centered on high-conviction holders anticipating a supply shock, while active traders debate the impact of upcoming exchange-led token burns and historical price patterns.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is currently generating significant community buzz due to its aggressive development of AI agent infrastructure on the Base ecosystem, with investors closely watching its revenue-linked utility and potential for broader institutional adoption. Traders are actively debating whether to accumulate during current volatility or wait for further price consolidation, while many remain bullish on the long-term potential of its expanding toolset.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending as market participants analyze potential acquisition rumors involving GameStop and weigh the company's aggressive share repurchase strategy against broader e-commerce sector volatility. Community discussions remain polarized, with many investors debating the feasibility of a high-profile takeover while others focus on technical setups and long-term valuation trends.

Reactive Network is the first parallelized interoperability execution layer, utilising a new form of smart contract we call reactive smart contracts.   Reactive smart contracts are able to react to on-chain events autonomously and execute their own user defined logic to initiate new transactions. This allows a virtually limitless number of use cases to achieve fully decentralized on-chain automation.

Reactive Network

Reactive Network is trending as investors discuss its potential for cross-chain automation and recent integration announcements, while the community focuses on its resilience during market volatility and the upcoming sunset of legacy token migration. Sentiment is high regarding the project's utility and increasing holder count, with many followers anticipating further exchange listings and long-term price appreciation.

What is Chronotech? Chrono.tech provides blockchain-based solutions for recruitment, HR and payment processes, reducing the barriers to accessing work and transferring funds securely in the global labor marketplace. The project’s suite of services - and native governance token TIME - are hosted on multiple blockchains and include LaborX.com, a peer-to-peer freelancer marketplace, TimeX.io, a Plasma-based cryptocurrency exchange; AUDT, an Australian dollar-backed stablecoin; and PaymentX, a crypto invoicing and payroll solution.  TIME token The TIME token is the native token of the Chrono.tech ecosystem and can be used within its products, e.g. to secure premium account status, as well as staking TIME on TimeWarp.finance to receive the revenues generated by all services. In November 2020, the original TIME token was upgraded to the new ERC677 standard, enabling it to be integrated with other DeFi protocols, allowing lower-cost transactions, and providing other advantages, while remaining fully ERC20-compatible. The new TIME 2.0 token contract also included up-to-date metadata about the project.  Chrono.tech products and ecosystem Chrono.tech aims to solve a series of problems in the global recruitment and employment markets. LaborX is Chrono.tech’s freelance work portal. The service allows freelancers and customers to organise work via digital agreements, powered by smart contracts. All payments are escrowed and made in cryptocurrency. Once a job is completed, escrowed payments are released automatically. A dispute resolution service is available in case of disagreement. TimeX is Chrono.tech’s cryptocurrency exchange. TimeX is a hybrid Plasma-based exchange that offers the benefits of both centralised and decentralised technologies. Use of Plasma allows for fast, secure trading of digital assets. The conventional interface provides a user-friendly trading experience. Based in Australia, TimeX is licensed and compliant with rules and best practices required by AUSTRAC, the country’s financial intelligence agency. TimeX is listed on CoinMarketCap https://coinmarketcap.com/exchanges/timex/ TimeWarp is the ecosystem’s DeFi yield farming application where TIME holders can stake their token to earn revenues generated by all products of the Chrono.tech product range. All 100% of revenues generated are being distributed to TIME holders on a weekly basis. AUDT is a stablecoin, hosted on the Ethereum blockchain and backed 1:1 with Australian dollars (AUD). Use of AUDT enables traders to move money into and out of the blockchain ecosystem from an Australian bank account, to store value in AUD on the blockchain and transfer funds anywhere in the world, quickly and easily. AUDT is one of the key fiat currencies traded on TimeX. AUDT is fully compliant with AUSTRAC requirements and undergoes regular audits conducted by a licensed, third party accounting firm. PaymentX is a multi-currency crypto payroll solution that enables individuals as well as businesses to integrate crypto payments into their day-to-day invoice processes. Contractors can submit professional invoices and specify a crypto wallet for payment. Companies can pay multiple invoices with one click, while the software converts the dollar-equivalent amount due into crypto automatically at the point of transaction, avoiding the need for manual calculations. TimeBridge is an in-house developed multi-blockchain tokenbridge that supports multiple blockchains such as Ethereum and BSC. It allows transferring of TIME tokens between networks.

Chronobank

Chronobank is currently generating significant social media conversation driven by its extremely low circulating supply and community-led efforts to create scarcity through buybacks and token burns. Investors are actively debating the asset's potential for volatile price swings, with many highlighting its history of rapid spikes and viewing current price levels as a strategic entry point.

Invesco CurrencyShares Japanese Yen Trust - Invesco CurrencyShares Japanese Yen Trust

Invesco CurrencyShares Japanese Yen Trust

FXY is experiencing significant volatility driven by intense speculation surrounding potential Bank of Japan intervention and the ongoing unwinding of the yen carry trade. The community is actively debating the threat of global financial instability if USD/JPY levels remain elevated, as traders monitor central bank policy signals and geopolitical tensions for further catalysts.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as the community closely monitors legislative progress on the Clarity Act, which many believe will solidify the token's role as a digital commodity for collateralized payments. While some investors are actively accumulating in anticipation of institutional adoption, others remain skeptical, fueling a polarized discussion around long-term utility versus persistent price stagnation.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is facing significant community debate as holders weigh the potential for long-term staking rewards and technical interoperability against persistent price volatility and concerns regarding inflationary tokenomics. While some investors view the current low valuation as a prime accumulation opportunity, others remain skeptical about the project's ability to maintain its market relevance amidst broader sector shifts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HCW Biologics Secures $7M Licensing Deal for Promising Immunotherapy

HCW Biologics (NASDAQ:HCWB) finalized an exclusive worldwide licensing agreement for its fusion immunotherapeutic candidate HCW11-006, marking a meaningful step in expanding its global development strategy.

Small Cap Stocks To Keep An Eye On - March 16th

CytomX Therapeutics, HCW Biologics, Direxion Daily MU Bull 2X Shares, Meiwu Technology, and AltC Acquisition are the five Small Cap stocks to watch today, according to MarketBeat's stock screener...

Promising Pharmaceutical Stocks To Keep An Eye On - March 16th

Eli Lilly and Company, CytomX Therapeutics, Pfizer, HCW Biologics, and AbbVie are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks...

Biotech Breakthroughs and Capital Moves Drive a Busy Market Week

A wave of biotech developments, strategic financings, and emerging-technology announcements shaped market narratives this week, highlighting how innovation across biopharma, AI-driven automation, energy technology, and crypto finance continues to drive investor attention. $CTMX, $NVDA, $HCWB, $KBLB, $CYN, $BMNR, $CLIK, $CIIT, $AIRS, $DFLI

<ul class="summary-bullets"><li>HCW Biologics stated that CAR-T cells manufactured with HCW9206 were significantly superior to those manufactured with standard methods.</li><li>The company said that CAR-Ts produced with its reagent are highly enriched in long-lived T memory stem cells.</li><li>HCW Biologics added that these CAR-Ts also displayed potent activity across distinct disease experimental models, namely, HIV-1 or B-cell leukemia.</li></ul>HCW Biologics Inc. (HCWB) shares soared more than 56% in Monday’s pre-market trade after the company announced positive research results for its CAR-T cell therapy.HCW Biologics stated that HCW9206, its proprietary, commercial-stage multi-cytokine fusion protein reagent, provides a new approach to generate CAR-T cells for immunotherapy with increased function at a cost-effective price.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/HCWB">HCW Biologics</a> trended in the ‘bullish’ territory with message volumes at ‘high’ levels.<h2 class="st-heading-2">HCW9206 CAR-Ts Outperform Standard Methods, Says Company</h2>HCW Biologics stated that CAR-T cells manufactured with HCW9206 were significantly superior to those manufactured with standard methods.The company said that CAR-Ts produced using its reagent are highly enriched in long-lived T-memory stem cells. HCW Biologics added that these CAR-Ts also displayed potent activity across distinct disease experimental models, namely, HIV-1 or B-cell leukemia.“Based on experimental models, HCW9206 has shown improvement in functional activities and persistence of CAR-Ts following adoptive transfer, a goal the industry has been trying to achieve for the last decade,” said HCW Biologics CEO, Dr. Hing C. Wong.The company stated that in its study, HCW9206 helped generate long-lasting duoCAR-T cells that showed strong HIV suppression in humanized mouse models using T cells from people living with HIV. The approach could extend CAR-T therapy durability and support efforts toward a functional HIV cure, it added.<h2 class="st-heading-2">Why Are CAR-T Cells Important?</h2>CAR-T cells represent a new way to treat cancer using the patient’s own immune system. These cells genetically modify a patient’s T cells so they can recognize and attack specific cancer cells, reducing damage to healthy tissue compared with traditional treatments.Additionally, once CAR-T cells are modified and infused into a patient’s body, they multiply and continue to fight cancer.<a href="https://stocktwits.com/symbol/HCWB">HCWB stock</a> is down 47% year-to-date and 96% over the past 12 months. The Vanguard Extended Market Index Fund ETF Shares (VXF) is up 20% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/soc-stock-soars-after-sable-resumes-oil-flow-from-california-pipeline/cZ32wB1RIfi">SOC Stock Rises Pre-Market After Energy Secretary Order Restarts Sable’s California Oil Pipeline</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

HCWB Stock Soars Pre-Market On Positive Research Results For CAR-T Cell Therapy

HCW Biologics said its proprietary multi-cytokine fusion protein reagent, HCW9206, offers a cost-effective way to generate higher-function CAR-T cells for immunotherapy.

Equity

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7R, and Others  DelveInsight

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7R, and Others | DelveInsight Alopecia Areata Market Set to...

HCW Biologics shares logged their best session in over three months on Monday after the firm revealed progress with a new cancer drug it thinks could be a multi-billion-dollar blockbuster.The stock jumped 60.8% to $5.55 on Monday, marking its best session since May 13, before adding another 0.5% in after-hours trading.The Florida-based biotech firm said it has developed an advanced form of pembrolizumab, which is sold by Merck as Keytruda and is considered the world’s top-selling FDA-approved immune checkpoint inhibitor.Drugs in this class are designed to help the immune system fight cancer, but they often only work for a small percentage of patients, and results are not always long-lasting.HCW Biologics said its version aims to go a step further: not only releasing the “brake” on the immune system but also activating immune cells and helping them infiltrate solid tumors, such as those seen in pancreatic and ovarian cancer.&nbsp;In early lab studies and mouse models, the company states that the therapy demonstrated stronger results than Keytruda alone, at dose levels that were well tolerated.CEO Hing C. Wong noted that global sales of checkpoint inhibitors topped $40 billion in 2024, underscoring the commercial potential if effectiveness can be improved.The company also sees potential for its therapy beyond cancer. HCW Biologics said checkpoint inhibitors may help clear “senescent” cells, which are aged cells that no longer divide but drive inflammation, making them a possible tool against age-related diseases.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 538% surge in 24-hour message volume, placing it among the most trending stocks on the platform.One user noted they had already taken profits, saying they made money on $HCWB and estimated early buyers likely gained 20–30%.<stembedurl>https://stocktwits.com/Camelinvesting/message/626495258</stembedurl>Another user praised HCW Biologics’ research, suggesting that since immune checkpoint inhibitors have shown success, improving on them could be the right path forward.<stembedurl>https://stocktwits.com/everything5/message/626494404</stembedurl><a href="https://stocktwits.com/symbol/HCWB">HCW Biologics’ stock</a> has declined 68.9% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

HCW Biologics (HCWB) shares logged their best session in over three months on Monday after the firm revealed progress with a new cancer drug it thinks could be a multi-billion-dollar blockbuster. | Image source: Getty Images

HCW Biologics Stock Scores Biggest Gain Since May As Cancer Drug Breakthrough Fuels Blockbuster Hopes

The biotech firm said its next-generation version of Keytruda showed stronger results in early studies and could eventually expand into both cancer and age-related disease treatments.

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.

HCWB
HCW Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HCWB News

HCWBHCW Biologics Inc